Placebos in Clinical Trials in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Placebos in Clinical Trials in Argentina

Placebos in Clinical Trials in Argentina – Cohortias the CRO of LATAM

Clinical trials are vital for medical progress, offering valuable insights into new treatments and interventions. However, the use of placebos in clinical trials often sparks ethical debates.

This blog examines the significance of placebos in clinical trials conducted in Argentina, delving into their purpose, impact, and the ethical considerations surrounding their use.

Understanding Placebos

Placebos are inactive substances or interventions that closely resemble the active treatment being investigated. They are commonly used as a control group in clinical trials to compare the effects of the experimental treatment against those of a neutral or non-active substance.

Placebos are designed to resemble the active treatment in appearance and administration method, but they lack the active ingredient being tested.

The Purpose of Placebos in Clinical Trials

Placebos serve multiple purposes in clinical trials. Firstly, they act as a reference point, allowing researchers to assess the true effectiveness of the experimental treatment. By comparing the outcomes of the active treatment group with those of the placebo group, researchers can determine the actual therapeutic effects of the intervention.

Secondly, placebos help differentiate between the physiological effects of the treatment and any psychological or placebo effects, facilitating an accurate evaluation of the intervention’s effectiveness.

Placebos in Clinical Trials in Argentina

Placebos in Clinical Trials in Argentina

Placebos in Clinical Trials in Argentina

Regulations and Ethical Considerations in Argentina

In Argentina, clinical trials involving placebos are subject to rigorous regulations and ethical guidelines to ensure participant safety and ethical conduct. The National Administration of Drugs, Foods, and Medical Devices (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica – ANMAT) oversees and regulates clinical trials, ensuring adherence to ethical standards.

According to these guidelines, the use of placebos must be ethically justified. If an established effective treatment exists, replacing it with a placebo is generally considered unethical. However, if no standard treatment is available, or when comparing a new treatment to an existing one, the use of placebos may be deemed acceptable.

Benefiting Participants and Advancing Medical Knowledge

Participants in clinical trials in Argentina are typically provided with informed consent, ensuring they are fully informed about the potential risks and benefits associated with participating in the trial, including the possibility of receiving a placebo. This process upholds the principles of autonomy, respect, and beneficence.

Clinical trials involving placebos in Argentina make significant contributions to medical knowledge by generating reliable evidence on the safety and efficacy of new treatments. They establish the gold standard for medical interventions, empowering healthcare professionals to deliver evidence-based care to patients.


Placebos play a critical role in clinical trials conducted in Argentina. While ethical considerations must be carefully addressed, the use of placebos allows researchers to evaluate the true effects of treatments, distinguish between physiological and placebo responses, and ultimately advance medical knowledge.

Through stringent regulations and ethical oversight, Argentina ensures that clinical trials involving placebos are conducted ethically, prioritizing participant safety and the development of effective medical interventions.

Placebos in Clinical Trials in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Placebos in Clinical Trials in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Placebos in Clinical Trials in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Placebos in Clinical Trials in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Placebos in Clinical Trials in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Placebos in Clinical Trials in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Placebos in Clinical Trials in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Placebos in Clinical Trials in Argentina

The Cohortias Team

Placebos in Clinical Trials in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Placebos in Clinical Trials in Argentina

Network & Partnerships